The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Abiomed Inc

Nasdaq: ABMD
Last

(U.S.) $60.79

Today's change-0.21 -0.34%
Updated February 27 4:00 PM EST. Delayed by at least 15 minutes.
 

Abiomed Inc

Nasdaq: ABMD
Last

(U.S.) $60.79

Today's change-0.21 -0.34%
Updated February 27 4:00 PM EST. Delayed by at least 15 minutes.

Abiomed Inc down (U.S.)$0.21

Abiomed Inc closed lower Friday, dropping (U.S.)$0.21 or 0.34% to (U.S.)$60.79. Over the last five days, shares have gained 0.73% and are currently 1.86% off of the 52-week high. Shares have outperformed the S&P 500 by 102.15% during the last year.

Key company metrics

  • Open(U.S.) $60.53
  • Previous close(U.S.) $61.00
  • High(U.S.) $61.53
  • Low(U.S.) $60.36
  • Bid / Ask-- / --
  • YTD % change+59.72%
  • Volume542,997
  • Average volume (10-day)478,653
  • Average volume (1-month)555,867
  • Average volume (3-month)466,471
  • 52-week range(U.S.) $20.29 to (U.S.) $61.94
  • Beta1.54
  • Trailing P/E141.61×
  • P/E 1 year forward121.58×
  • Forward PEG6.88×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.43
Updated February 27 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+8.65%

Based on its net profit margin of 8.65%, Abiomed Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.04%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014
Revenue62524950
Total other revenue--------
Total revenue62524950
Gross profit52423940
Total cost of revenue10101010
Total operating expense48485047
Selling / general / administrative30293229
Research & development8998
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income144-24
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax144-14
Income after tax134-24
Income tax, total1000
Net income134-24
Total adjustments to net income--------
Net income before extra. items134-24
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items134-24
Inc. avail. to common incl. extra. items134-24
Diluted net income134-24
Dilution adjustment----00
Diluted weighted average shares43424042
Diluted EPS excluding extraordinary itemsvalue per share0.300.09-0.040.09
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.300.09-0.040.09